X0407 4 2023-06-16 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001274139 HERSHBERG ROBERT C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 1 0 0 0 0 Class A Common Stock 2023-06-16 4 A 0 12612 0.00 A 38619 D Stock Option (Right to Buy) 8.92 2023-06-16 4 A 0 25224 0.00 A 2024-06-16 2033-06-16 Class A Common Stock 25224 25224 D Stock Option (Right to Buy) 6.20 2023-06-14 2032-06-14 Class A Common Stock 36290 36290 D Stock Option (Right to Buy) 18.00 2022-04-15 2031-04-15 Class A Common Stock 12500 12500 D Stock Option (Right to Buy) 2.22 2030-03-19 Class A Common Stock 525000 525000 D Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 16, 2024 or the day prior to the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer. The shares subject to this option will vest and become exercisable on the earlier of June 16, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer. One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 16, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. /s/ Jonathan Golightly, attorney-in-fact 2023-06-21